Genetics of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular and Cellular Probes

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mcp.2016.11.001PMID 27818248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• O 1-7-4-2 Abnormal autophagy / lysosome function may play some role in Parkinson ’ s disease

  2018cited by this paper
• The Neurogenetics of Parkinson’s Disease and Putative Links to Other Neurodegenerative Disorders

  2017cited by this paper
• A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration

  2016cited by this paper
• A Novel Nonsense Mutation in DNAJC6 Expands the Phenotype of Autosomal‐Recessive Juvenile‐Onset Parkinson's Disease

  2016cited by this paper
• DNAJC6 Mutations Associated With Early‐Onset Parkinson's Disease

  2016cited by this paper
• Identification of TMEM230 mutations in familial Parkinson’s disease

  2016cited by this paper
• RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies.

  2016cited by this paper
• Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

  2016cited by this paper
• Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population.

  2016cited by this paper
• Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease.

  2016cited by this paper
• Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force

  2016cited by this paper
• Launching the movement disorders society genetic mutation database (MDSGene)

  2016cited by this paper
• Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases

  2016cited by this paper
• Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease

  2016cited by this paper
• RAB39B mutations are a rare finding in Parkinson disease patients.

  2016cited by this paper
• Whole-Exome Sequencing in Familial Parkinson Disease.

  2016cited by this paper
• Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.

  2016cited by this paper
• Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease.

  2016cited by this paper
• Large C9orf72 repeat expansions are seen in Chinese patients with sporadic amyotrophic lateral sclerosis.

  2016cited by this paper
• A new F‐box protein 7 gene mutation causing typical Parkinson's disease

  2015cited by this paper
• The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms

  2015cited by this paper
• Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

  2015cited by this paper
• Cumulative genetic risk and age at onset in Parkinson's disease

  2015cited by this paper
• Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases

  2015cited by this paper
• Spreading of pathology in neurodegenerative diseases: a focus on human studies

  2015cited by this paper
• Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.

  2015cited by this paper
• Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease.

  2015cited by this paper
• EIF4G1 mutations do not cause Parkinson's disease.

  2015cited by this paper
• CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.

  2015cited by this paper
• Novel LRRK2 mutations in Parkinsonism.

  2015cited by this paper
• Genetic risk and age in Parkinson's disease: Continuum not stratum

  2015cited by this paper
• Probing the epigenome by EWAS: A new era in brain disease research

  2015cited by this paper
• Impact of Parkinson's disease risk loci on age at onset

  2015influential reference
• Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

  2015cited by this paper
• DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients

  2015cited by this paper
• Class II HLA interactions modulate genetic risk for multiple sclerosis

  2015cited by this paper
• Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers

  2014cited by this paper
• Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson Disease

  2014cited by this paper
• DNAJ mutations are rare in Chinese Parkinson's disease patients and controls.

  2014cited by this paper
• Hereditary dystonia and parkinsonism: two sides of the same coin?

  2014cited by this paper
• DNAJC13 mutations in Parkinson disease.

  2014cited by this paper
• Initial management of Parkinson’s disease

  2014cited by this paper
• Recent Advances and Future Challenges in the Genetics of Multiple Sclerosis

  2014cited by this paper
• Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci

  2014cited by this paper
• EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts

  2014cited by this paper
• Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

  2014cited by this paper
• Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.

  2014cited by this paper
• Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals.

  2014cited by this paper
• Cross-tissue methylomic profiling strongly implicates a role for cortex-specific deregulation of ANK1 in Alzheimer’s disease neuropathology

  2014cited by this paper
• G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome

  2013cited by this paper
• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

  2013cited by this paper
• Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset Parkinsonism

  2013cited by this paper
• A novel α-synuclein missense mutation in Parkinson disease

  2013cited by this paper
• The Sac1 Domain of SYNJ1 Identified Mutated in a Family with Early‐Onset Progressive Parkinsonism with Generalized Seizures

  2013cited by this paper
• Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease

  2013cited by this paper
• The function of α-synuclein.

  2013cited by this paper
• SNCA: Major genetic modifier of age at onset of Parkinson's disease

  2013cited by this paper
• Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

  2013cited by this paper
• Advances in the genetics of Parkinson disease

  2013cited by this paper
• [Epidemiology of Parkinson's disease].

  2013cited by this paper
• Genetic analysis of the RAB39B gene in Chinese Han patients with Parkinson's disease.

  2013cited by this paper
• DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability.

  2013cited by this paper
• α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?

  2013cited by this paper
• Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs.

  2012cited by this paper
• Systematic Review and UK‐Based Study of PARK2 (parkin), PINK1, PARK7 (DJ‐1) and LRRK2 in early‐onset Parkinson's disease

  2012influential reference
• Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2

  2012cited by this paper
• A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism

  2012cited by this paper
• Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database

  2012influential reference
• A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

  2012cited by this paper
• The genetics and neuropathology of Parkinson’s disease

  2012cited by this paper
• A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease

  2012cited by this paper
• Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism.

  2012cited by this paper
• Genome-wide association study confirms extant PD risk loci among the Dutch

  2011cited by this paper
• VPS35 mutations in Parkinson disease.

  2011influential reference
• Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.

  2011cited by this paper
• Towards unveiling the genetics of neurodegenerative diseases.

  2011cited by this paper
• Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

  2011cited by this paper
• Translation initiator EIF4G1 mutations in familial Parkinson disease.

  2011cited by this paper
• A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.

  2011influential reference
• Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

  2011cited by this paper
• Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy

  2011cited by this paper
• Integrating common and rare genetic variation in diverse human populations

  2010cited by this paper
• Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease

  2010cited by this paper
• Bayes factors in complex genetics

  2010cited by this paper
• A map of human genome variation from population-scale sequencing

  2010cited by this paper
• Clinical progression in Parkinson disease and the neurobiology of axons

  2010cited by this paper
• Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21

  2010cited by this paper
• Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

  2009cited by this paper
• Genomewide association study for susceptibility genes contributing to familial Parkinson disease

  2009cited by this paper
• Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease

  2009cited by this paper
• LRRK2 in Parkinson’s disease: function in cells and neurodegeneration

  2009cited by this paper
• Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

  2009cited by this paper
• Common variants on chromosome 6p22.1 are associated with schizophrenia

  2009cited by this paper
• Emerging pathways in genetic Parkinson’s disease: Autosomal‐recessive genes in Parkinson’s disease – a common pathway?

  2008cited by this paper
• Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays.

  2008cited by this paper
• Characterization of PLA2G6 as a locus for dystonia‐parkinsonism

  2008cited by this paper
• A critical reappraisal of current staging of Lewy-related pathology in human brain

  2008cited by this paper
• Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

  2008cited by this paper
• Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

  2007cited by this paper
• Multiple Roles of Auxilin and Hsc70 in Clathrin‐Mediated Endocytosis

  2007influential reference

• Unveiling the biochemical potential of Acacia jacquemontii as a therapeutic agent in parkinson's disease: A multi-model in Vitro, In Vivo, and In Silico Study.

  2026cites this paper
• Extracellular Vesicle‐Mediated Delivery of Constrained Peptides Disrupts the Pathogenic Interaction of LRRK2‐FADD in Parkinson's Disease

  2026cites this paper
• Effects of Smoking on Motor and Non-Motor Symptoms in Parkinson's Disease: A Statistical Approach

  2025cites this paper
• Parkinson's disease‐linked Kir4.2 mutation R28C leads to loss of ion channel function

  2025cites this paper
• Association of the rs823144 variant of the RAB29 gene with the activity of lysosomal hydrolases in blood cells and risk of Parkinson’s disease

  2025cites this paper
• The role of cytochrome P450 and gut microbiome in drug metabolism: Insights into Parkinson disease treatment.

  2025cites this paper
• Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson's Disease: Exploring Nanoparticle-based Gene Therapies.

  2025cites this paper
• Begutachtung der Parkinson-Krankheit als Berufskrankheit

  2025cites this paper
• Systematic review of electron transfer study in DNA relevant to Parkinson’s disease and scanning tunneling microscopy

  2025cites this paper
• Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1‐ and LRRK2‐Associated Parkinson's Disease Patient‐Derived Cells

  2025cites this paper
• Drosophila as an Animal Model To Determine the Functional and Behavioral Significance of Dopamine Transporter Genetic Variations Associated with Brain Disorders.

  2025cites this paper
• Impact of Y chromosome loss on the risk of Parkinson's disease and progression

  2025cites this paper
• Unraveling the Co-Morbidity between COVID-19 and Neurodegenerative Diseases Through Multi-scale Graph Analysis: A Systematic Investigation of Biological Databases and Text Mining

  2025cites this paper
• Miro1: A potential target for treating neurological disorders.

  2025cites this paper
• Effects of glucocerebrosidase gene variations on the risk of Parkinson’s disease dementia: a meta-analysis

  2025cites this paper
• Study of Brain Cells in Neurodegenerative Diseases: Raman Microspectroscopy and Scanning Ion-Conductance Microscopy

  2025cites this paper
• Mitochondrial Dysfunction in the Pathogenesis of Parkinson Disease: Current Concepts and Potential Therapeutic Strategies

  2025cites this paper
• Nanoparticle-based strategies for overcoming the blood-brain barrier in CNS disorders and brain cancer: precision diagnostics and therapeutics for Alzheimer's, Parkinson's, multiple sclerosis, and glioblastoma.

  2025cites this paper
• From copper homeostasis to cuproptosis: a new perspective on CNS immune regulation and neurodegenerative diseases

  2025influential citation
• Pathway Analysis and Genetic Markers in Parkinson’s Disease: Insights into Subtype-Specific Mechanisms

  2025cites this paper
• (Dys)regulation of the Immune System in Parkinson’s Disease: Methodologies, Techniques, and Key Findings from Human Studies

  2025cites this paper
• Extracellular vesicles and mitochondria in central nervous system diseases

  2025cites this paper
• Variations in ADAR editing of nonsense-mediated decay targets in PD males and females

  2025cites this paper
• Mitochondrial Quality Control in Neurodegeneration and Cancer: A Common Denominator, Distinct Therapeutic Challenges

  2025cites this paper
• Outlook of SNCA (α-synuclein) transgenic fly models in delineating the sequel of mitochondrial dysfunction in Parkinson's disease.

  2025cites this paper
• The Search for Answers: Causes, Risk Factors, and Current Research in Neurodegenerative Disorders

  2025cites this paper
• A Review on Therapeutic Strategies against Parkinson's Disease: Current Trends and Future Perspectives.

  2024cites this paper
• Single Nucleotide Polymorphism-based Identification of Bacterial Artificial Chromosome-mediated Homologous Recombination.

  2024cites this paper
• Developmental origins of Parkinson’s disease risk: perinatal exposure to the organochlorine pesticide dieldrin leads to sex-specific DNA modifications in critical neurodevelopmental pathways in the mouse midbrain

  2024cites this paper
• Advances in Parkinson's disease research - A computational network pharmacological approach.

  2024cites this paper
• Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputation

  2024cites this paper
• Midnolin, a Genetic Risk Factor for Parkinson’s Disease, Promotes Neurite Outgrowth Accompanied by Early Growth Response 1 Activation in PC12 Cells

  2024cites this paper
• The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases

  2024cites this paper
• Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite.

  2024cites this paper
• Identification of metabolic pathways and key genes associated with atypical parkinsonism using a systems biology approach

  2024cites this paper
• The Impact of 90 Parkinson’s Disease-Risk Single Nucleotide Polymorphisms on Urinary Bis(monoacylglycerol)phosphate Levels in the Prodromal and PD Cohorts

  2024cites this paper
• Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease.

  2024cites this paper
• Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.

  2024cites this paper
• Clinical Report on an Implant-Supported Overdenture in a Parkinson’s Patient

  2024cites this paper
• TIN-X version 3: update with expanded dataset and modernized architecture for enhanced illumination of understudied targets

  2024cites this paper
• Enhancing mitochondrial proteolysis alleviates alpha-synuclein-mediated cellular toxicity

  2024cites this paper
• Developmental origins of parkinson's disease risk: perinatal exposure to the organochlorine pesticide dieldrin leads to sex-specific DNA modifications in critical neurodevelopmental pathways in the mouse midbrain.

  2024cites this paper
• The role of orexin in Parkinson's disease

  2024cites this paper
• Arrestin‐3 binds parkin and enhances parkin‐dependent mitophagy

  2024cites this paper
• Molecular dynamics studies reveal the structural impacts of LRRK2 R1441C and LRRK2 D1994A mutations in Parkinson's disease

  2024cites this paper
• Comparative Molecular Docking Studies of Selected Phytoconstituents on the Dopamine D3 Receptor (PDB ID: 3PBL) as Potential Anti-Parkinson’s Agents

  2023cites this paper
• The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders

  2023cites this paper
• Gene signals and SNPs associated with Parkinson's disease: A nutrigenomics and computational prospective insights.

  2023cites this paper
• New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders.

  2023cites this paper
• Pain in monogenic Parkinson’s disease: a comprehensive review

  2023cites this paper
• Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease

  2023cites this paper
• Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue

  2023cites this paper
• Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery.

  2023cites this paper
• Structural Variants of Midnolin, a Genetic Risk Factor for Parkinson's Disease, in a Yamagata Cohort.

  2023cites this paper
• Neuronal Vulnerability to Degeneration in Parkinson's Disease and Therapeutic Approaches.

  2023cites this paper
• Protein Biomarkers Shared by Multiple Neurodegenerative Diseases Are Calmodulin-Binding Proteins Offering Novel and Potentially Universal Therapeutic Targets

  2023cites this paper
• Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease

  2023cites this paper
• Mitochondria in Cell-Based Therapy for Stroke

  2023cites this paper
• Comparative analysis of four nuclei in the human brainstem: Individual differences, left-right asymmetry, species differences

  2023cites this paper
• Alterations in RNA editing in skeletal muscle following exercise training in individuals with Parkinson’s disease

  2023influential citation
• Intranasal delivery of mitochondrial protein humanin rescues cell death and promotes mitochondrial function in Parkinson's disease

  2023cites this paper
• Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review

  2023cites this paper
• Caffeine intake interacts with Asian gene variants in Parkinson's disease: a study in 4488 subjects

  2023cites this paper
• Frequency of Hereditary and GBA1‐Related Parkinsonism in Latin America: A Systematic Review and Meta‐Analysis

  2023cites this paper
• Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research

  2023cites this paper
• WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective

  2023cites this paper
• The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders

  2022cites this paper
• Detailed insight into the pathophysiology and the behavioral complications associated with the Parkinson's disease and its medications

  2022cites this paper
• Systematic review of Mendelian randomization studies on Parkinson’s disease

  2022cites this paper
• The role of nutrition on Parkinson’s disease: a systematic review

  2022cites this paper
• Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?

  2022cites this paper
• A Roadmap for Future Parkinson's Pharmacogenomics in Asia

  2022cites this paper
• Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases

  2022cites this paper
• Update on CSF Biomarkers in Parkinson’s Disease

  2022influential citation
• Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease

  2022cites this paper
• Nutrient‐sensing amyloid metastasis

  2022cites this paper
• Relationships of Nutritional Factors and Agrochemical Exposure with Parkinson’s Disease in the Province of Brescia, Italy

  2022cites this paper
• Site-specific mitochondrial dysfunction in neurodegeneration.

  2022cites this paper
• Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease

  2022influential citation
• Subthalamic deep brain stimulation in Parkinson's disease with SNCA mutations: Based on the follow‐up to 10 years

  2022cites this paper
• The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases.

  2022cites this paper
• High-Throughput Sequencing Haplotype Analysis Indicates in LRRK2 Gene a Potential Risk Factor for Endemic Parkinsonism in Southeastern Moravia, Czech Republic

  2022cites this paper
• Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains

  2022cites this paper
• Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease

  2022cites this paper
• Protein S-sulfhydration: Unravelling the prospective of hydrogen sulfide in the brain, vasculature and neurological manifestations.

  2022cites this paper
• Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease

  2022cites this paper
• Neurexin 2 p.G849D variant, implicated in Parkinson’s disease, increases reactive oxygen species, and reduces cell viability and mitochondrial membrane potential in SH-SY5Y cells

  2022cites this paper
• Emerging roles of leptin in Parkinson's disease: chronic inflammation, neuroprotection and more?

  2022cites this paper
• The Therapeutic Potential of Salidroside for Parkinsonʼs Disease

  2022cites this paper
• Impact of cognition-related single nucleotide polymorphisms on brain imaging phenotype in Parkinson’s disease

  2022cites this paper
• Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches

  2022cites this paper
• Lipid Nanoparticles: Promising Treatment Approach for Parkinson’s Disease

  2022cites this paper
• Natural product-based pharmacological studies for neurological disorders

  2022cites this paper
• Decoding the Role of Familial Parkinson’s Disease-Related Genes in DNA Damage and Repair

  2022influential citation
• Exosome Release Is Modulated by the Mitochondrial-Lysosomal Crosstalk in Parkinson’s Disease Stress Conditions

  2021cites this paper
• Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson's Disease

  2021cites this paper
• Enteric Neurotoxicity and Salsolinol

  2021cites this paper
• Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans.

  2021cites this paper
• Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation

  2021cites this paper
• Neurodegenerative disorders and the current state, pathophysiology and management of Parkinson's disease.

  2021cites this paper